PHARMA AND BIOTECH CEOS
Your Board Evaluates You. Your Team Reports to You. Who Develops You?
An outside perspective, unconstrained by internal politics, for the daily decisions and the consequential ones.
Coached 150+ Leaders at:
Who you are under pressure is either scaling your company or stalling it.
Conjunction Leadership works with pharma and biotech CEOs, developing the nervous system regulation and leadership presence that enterprise scale requires. This work addresses the gap between knowing what to do and actually doing it when the stakes are high.
The Pattern You Can’t See Is the One Running You
You revert to problem-solving when your team needs direction. You prepare obsessively for board meetings because you don’t trust your presence. You avoid the conversation with your underperforming CMO because confrontation registers as threat.
These patterns run deeper than skill gaps. Your body learned over decades that this is how you survive. Every crisis you managed alone built the wiring: this is safety.
At Conjunction Leadership, we work at the identity level. We help pharma and biotech CEOs rewire the belief systems and nervous system patterns that determine how you show up when it matters most.
Most Coaches Work On Behaviors. We Work On The Identity Driving Your Patterns.
Your nervous system runs a different program. When someone questions your decision, your chest tightens. During board pushback, your hands clench. When you need to give critical feedback, you postpone for weeks because your body registers confrontation as a threat.
You know what to do. When pressure hits, your biology wins. Every time.
The TriAxis™ framework addresses what keeps you reactive. Belief that your value comes from being the smartest person in the room. Biology that registers adversity as a threat to your identity. Behavior that defaults to familiar modes because that’s where you feel secure.
All-access coaching support. Deep life sciences fluency. Absolute confidentiality.
You’re Ready for This If...
You’re the CEO or Founder of a pharma or biotech company with 150-350+ people preparing for clinical milestones, regulatory submissions, or commercial scale.
Something needs to shift. Your calendar is full of strategic work, but you revert to old patterns when pressure hits. Board meetings require faking confidence instead of showing up grounded. You’ve tried behavioral tactics. They work until pressure hits. Then the old pattern takes over because the wiring underneath hasn’t changed.
This work is for you.
Here’s what likely happened:
You kept assuming more responsibility without letting go of what was below you. Now you’re operating at a breadth that’s unsustainable at the next level. Leadership sees it. They’re waiting for you to see it too.
What Enterprise Leadership Actually Looks Like
Your team notices before you name it. This is the shift: enterprise leadership that doesn’t require willpower to maintain. You operate from a regulated presence instead of rehearsed composure.
1
Your Presence Becomes Calmer
Board meetings become strategic dialogue. You show up calm in complexity because your nervous system is regulated. The composure is real.
2
Conversations Happen When They Need To
Critical feedback to underperforming VPs happens in week two instead of month six. Confrontation stops registering as a threat in your biology.
3
Your Decisions Come from Clarity
C-suite hiring decisions that used to take months resolve in weeks. You trust your judgment without the three-day spiral of second-guessing.
4
Your Leadership Team Develops Real Autonomy
Your direct reports develop confidence to lead their functions without constant oversight. They make strategic calls without waiting to read your stress signals.
5
Board Interactions Shift from Performance to Partnership
Your board experiences you as peer architect. Investor relationships deepen because they see the enterprise CEO they need for scale or exit.
6
Leadership Becomes Sustainable
Professional demands integrate with personal health and relationships. You have space to think beyond next quarter because you’re not burning energy managing your internal state.
The Cost Of Running Old Patterns At New Scale
Your stress becomes their stress. Your hesitation to confront becomes their permission to avoid. Your reactive patterns in board meetings become their model for high-stakes conversations.
The pharma and biotech CEOs who scale successfully rewire their nervous system before it rewires their organization. Your leadership team is learning from you right now. The question is what they’re learning.
Client Transformation Stories
Real transformations from VPs, SVPs, and CEOs across Life Sciences and AgTech.
I've shifted from reactive problem-solving to proactive, forward-looking reviews. My team is more capable, and I'm spending less time in the weeds doing work they should own. I've even referred one of my senior leaders to work with Jim. Ultimately, Jim provides the impartial perspective every CEO needs—someone who can help you see patterns you're too close to notice. This work has made me a more effective leader and helped me build a stronger executive team.
Jim is a great facilitator who is inspiring, encouraging, thought provoking, and values connection. He will get you thinking at your core, stretch you to reach the impossible, and creates a safe space for you to be your best self!
Jim is a trusted partner for any executive navigating the complexities of high-stakes transitions while refining and redefining who they need to become as a leader.
About Jim Bishop
Jim Bishop spent 20+ years inside Fortune 500 life sciences companies, including Eli Lilly, Roche, and Elanco, before founding Conjunction Leadership. He knows what Phase 2b timelines do to your org chart and why investor boards ask different questions than governance boards. He speaks your language because he comes from your world.
150+ senior leaders coached across 5,000+ hours. Other coaches make you explain your world. Jim already speaks it.
Deep Life Sciences Fluency
Clinical development stages, FDA feedback cycles, and the specific board governance structures that shape life sciences leadership. No translation required.
Candor Over Comfort
Your board evaluates you. Your team reports to you. Your peers are competitors. You need someone who will say "you’re part of the problem" when you’re part of the problem.
Confidential Strategic Partnership
In an industry where everyone knows everyone, discretion matters. What we discuss stays between us.
You’ll Know Within 20 Mins If This Fits
If you’re leading 150-300+ people in pharma or biotech and you recognize the patterns described here, let’s have a conversation. Especially if your body said "yes, that’s exactly what’s happening" while your mind tried to explain why your situation is different.
No pitch. No pressure. You’ll know within twenty minutes if this is right.
FAQs
How is this different from other executive coaching?
We work on identity and nervous system: who you need to become to lead enterprise scale, and how to rewire the patterns that keep overriding your intentions when pressure hits. Behavioral tactics work until the stakes get high. We address the wiring.
What if I’ve tried coaching before and it didn’t stick?
Behavioral changes work until pressure hits. We address the root: the belief, the biology that interprets complexity as threat, the patterns that default to familiar modes. When those shift at the identity level, the behaviors hold under pressure.
How do I know if this will work for me?
The strategy session exists for this reason. We identify your patterns, determine fit, and outline what success looks like. If it’s not a fit, I’ll tell you directly and point you toward what might serve you better.
What does the engagement actually look like?
A retainer-based partnership with continuous access. When you’re facing a critical hire decision or a board dynamic shifts, you reach out. Most CEOs structure formal sessions once or twice per month. The value lives in the access between those conversations.
Is this confidential?
Nothing we discuss leaves the room unless you explicitly direct otherwise. Your board and team don’t know unless you want them to. Non-negotiable.
What’s the investment?
We discuss investment during our initial conversation, tailored to your situation. CEOs who work with Conjunction Leadership typically see this as essential leadership infrastructure, not a discretionary expense.